AKT2 anticorps (N-Term)
Aperçu rapide pour AKT2 anticorps (N-Term) (ABIN2198623)
Antigène
Voir toutes AKT2 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- N-Term
-
Réactivité croisée
- Humain, Souris
-
Réactivité croisée (Details)
- Calculated cross reactivity: Hu Mo
-
Attributs du produit
- AKT2, NT (RAC-beta Serine/Threonine-protein Kinase, RAC-PK-beta, Protein Kinase Akt-2, Protein Kinase B, beta, PKB beta)
-
Purification
- Purified by Protein G affinity chromatography.
-
Immunogène
- Synthetic peptide selected from the N-terminal region of human AKT2 (KLH).
-
Isotype
- IgG
-
-
-
-
Indications d'application
- Optimal working conditions should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- Supplied as a liquid in PBS, 0.09 % sodium azide.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- -20 °C
-
Stockage commentaire
- -20°C
-
-
- AKT2 (V-Akt Murine Thymoma Viral Oncogene Homolog 2 (AKT2))
-
Autre désignation
- AKT2
-
NCBI Accession
- NP_001617
-
UniProt
- P31751
-
Pathways
- Signalisation PI3K-Akt, Signalisation RTK, AMPK Signaling, Signalisation TLR, Cellular Glucan Metabolic Process, Regulation of Carbohydrate Metabolic Process, Hepatitis C, VEGF Signaling
Antigène
-